Filing Details
- Accession Number:
- 0001209191-14-024779
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-02 18:01:59
- Reporting Period:
- 2014-04-01
- Filing Date:
- 2014-04-02
- Accepted Time:
- 2014-04-02 18:01:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1593034 | Endo International Plc | ENDP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263102 | John Delucca | C/O Endo International Plc No. 33 Fitzwilliam Square Dublin L2 2 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-04-01 | 10,384 | $16.80 | 31,980 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-04-01 | 10,384 | $68.46 | 21,596 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 2007 Stock Incentive Plan Stock Options (NQ) | Disposition | 2014-04-01 | 10,384 | $0.00 | 10,384 | $16.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-12 | No | 4 | M | Direct |
Footnotes
- On March 10, 2014, in connection with his personal financial planning, Mr. Delucca placed 25,242 of the shares underlying his stock options into a 10b5-1 pre-set selling program (the "Delucca Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Delucca Pre-Set Selling Program, which leaves 14,858 remaining shares (underlying options) in the current Delucca Pre-Set Selling Program. The Delucca Pre-Set Selling Program's initial termination date is the earlier of December 31, 2014 or the date all shares under the program are sold.
- This represents the average price at which Mr. Delucca's ordinary shares were sold on April 1, 2014.
- Mr. Delucca's stock options that were granted under the 2007 Stock Incentive Plan on March 12, 2009 were generally exercisable 25% per year on each of March 12, 2010, March 12, 2011, March 12, 2011, and March 12, 2013.
- These securities were granted to Mr. Delucca in 2009 in consideration of his services on the Endo Health Solutions Inc. Board of Directors.
Billionaire Hedge Funds
